Abstract:
BACKGROUND:Bariatric and metabolic surgery is used as a treatment for patients with severe and complex obesity. However, there is a need to improve outcome selection and reporting in bariatric surgery trials. A Core Outcome Set (COS), an agreed minimum set of outcomes reported in all studies of a specific condition, may achieve this. Here, we present the development of a COS for BARIAtric and metabolic surgery Clinical Trials-the BARIACT Study. METHODS AND FINDINGS:Outcomes identified from systematic reviews and patient interviews informed a questionnaire survey. Patients and health professionals were surveyed three times and asked to rate the importance of each item on a 1-9 scale. Delphi methods provided anonymised feedback to participants. Items not meeting predefined criteria were discarded between rounds. Remaining items were discussed at consensus meetings, held separately with patients and professionals, where the COS was agreed. Data sources identified 2,990 outcomes, which were used to develop a 130-item questionnaire. Round 1 response rates were moderate but subsequently improved to above 75% for other rounds. After rounds 2 and 3, 81 and 14 items were discarded, respectively, leaving 35 items for discussion at consensus meetings. The final COS included nine items: "weight," "diabetes status," "cardiovascular risk," "overall quality of life (QOL)," "mortality," "technical complications of the specific operation," "any re-operation/re-intervention," "dysphagia/regurgitation," and "micronutrient status." The main limitation of this study was that it was based in the United Kingdom only. CONCLUSIONS:The COS is recommended to be used as a minimum in all trials of bariatric and metabolic surgery. Adoption of the COS will improve data synthesis and the value of research data. Future work will establish methods for the measurement of the outcomes in the COS.
journal_name
PLoS Medjournal_title
PLoS medicineauthors
Coulman KD,Hopkins J,Brookes ST,Chalmers K,Main B,Owen-Smith A,Andrews RC,Byrne J,Donovan JL,Mazza G,Reeves BC,Rogers CA,Thompson JL,Welbourn R,Wordsworth S,Blazeby JM,BARIACT working group.doi
10.1371/journal.pmed.1002187subject
Has Abstractpub_date
2016-11-29 00:00:00pages
e1002187issue
11eissn
1549-1277issn
1549-1676pii
PMEDICINE-D-16-02378journal_volume
13pub_type
指南,杂志文章相关文献
PLOS MEDICINE文献大全abstract:BACKGROUND:Immunohistochemical markers are often used to classify breast cancer into subtypes that are biologically distinct and behave differently. The aim of this study was to estimate mortality for patients with the major subtypes of breast cancer as classified using five immunohistochemical markers, to investigate ...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析
doi:10.1371/journal.pmed.1000279
更新日期:2010-05-25 00:00:00
abstract:BACKGROUND:Despite repeated outbreaks, in particular the devastating 2014-2016 epidemic, there is no effective treatment validated for patients with Ebola virus disease (EVD). Among the drug candidates is the broad-spectrum polymerase inhibitor favipiravir, which showed a good tolerance profile in patients with EVD (JI...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002535
更新日期:2018-03-27 00:00:00
abstract:BACKGROUND:The identification and characterization of tumor suppressor genes has enhanced our understanding of the biology of cancer and enabled the development of new diagnostic and therapeutic modalities. Whereas in past decades, a handful of tumor suppressors have been slowly identified using techniques such as link...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0050114
更新日期:2008-05-27 00:00:00
abstract:BACKGROUND:Rare diseases affect as many as 60 million people in the United States and Europe. However, most rare diseases lack effective therapies and are in critical need of clinical research. Our objective was to determine the frequency of noncompletion and nonpublication of trials studying rare diseases. METHODS AN...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002966
更新日期:2019-11-21 00:00:00
abstract:BACKGROUND:Diarrhea remains a leading cause of mortality among young children in low- and middle-income countries. Although the evidence for individual diarrhea prevention and treatment interventions is solid, the effect a comprehensive scale-up effort would have on diarrhea mortality has not been estimated. METHODS A...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1000428
更新日期:2011-03-01 00:00:00
abstract:BACKGROUND:Policymakers worldwide are considering requiring warnings for sugary drinks. A growing number of experimental studies have examined sugary drink warnings' impacts, but no research to our knowledge has synthesized this literature. To inform ongoing policy debates, this study aimed to identify the effects of s...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析
doi:10.1371/journal.pmed.1003120
更新日期:2020-05-20 00:00:00
abstract::Mirjam Kretzschmar and colleagues describe the BCoDE project, which uses a pathogen-based incidence approach to better estimate the infectious disease burden in Europe. ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001205
更新日期:2012-01-01 00:00:00
abstract::On the 30th anniversary of the Chernobyl disaster, Amina Aitsi-Selmi and Virginia Murray reflect on the importance of disaster preparedness. ...
journal_title:PLoS medicine
pub_type: 历史文章,杂志文章
doi:10.1371/journal.pmed.1002017
更新日期:2016-04-25 00:00:00
abstract:BACKGROUND:Temporary labor migration is an increasingly important mode of migration that generates substantial remittance flows, but raises important concerns for migrant well-being. The migration and health literature has seen a growing call for longitudinal, binational surveys that compare migrants to relevant non-mi...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003081
更新日期:2020-03-31 00:00:00
abstract:BACKGROUND:Attrition during the period from HIV testing to antiretroviral therapy (ART) initiation is high worldwide. We assessed whether same-day HIV testing and ART initiation improves retention and virologic suppression. METHODS AND FINDINGS:We conducted an unblinded, randomized trial of standard ART initiation ver...
journal_title:PLoS medicine
pub_type: 杂志文章,随机对照试验
doi:10.1371/journal.pmed.1002357
更新日期:2017-07-25 00:00:00
abstract:BACKGROUND:Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and implementation of a risk score model for CKD would allow comparison of the risks and benefits of adding potentially nephrotoxic antiretrovirals to a treatment ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001809
更新日期:2015-03-31 00:00:00
abstract:BACKGROUND:This paper examines the efforts of consultants affiliated with Philip Morris (PM), the world's leading transnational tobacco corporation, to influence scientific research and training in Thailand via the Chulabhorn Research Institute (CRI). A leading Southeast Asian institute for environmental health science...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0050238
更新日期:2008-12-23 00:00:00
abstract:BACKGROUND:Patients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3-6 months, yet their risk remains heterogeneous. Thus, prolonging anticoagulant treatment should be consi...
journal_title:PLoS medicine
pub_type: 杂志文章,随机对照试验
doi:10.1371/journal.pmed.1003142
更新日期:2020-06-26 00:00:00
abstract:BACKGROUND:It is unclear whether an upper gastrointestinal bleed is an isolated gastrointestinal event or an indicator of a deterioration in a patient's overall health status. Therefore, we investigated the excess causes of death in individuals after a non-variceal bleed compared with deaths in a matched sample of the ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001437
更新日期:2013-01-01 00:00:00
abstract:BACKGROUND:There is an urgent need to identify tools able to provide reliable information on the cause of death in low-income regions, since current methods (verbal autopsy, clinical records, and complete autopsies) are either inaccurate, not feasible, or poorly accepted. We aimed to compare the performance of a standa...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002171
更新日期:2016-11-22 00:00:00
abstract:BACKGROUND:Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, an...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0050032
更新日期:2008-02-01 00:00:00
abstract::Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics. ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002043
更新日期:2016-06-14 00:00:00
abstract:BACKGROUND:Clear recognition of the damaging effects of poverty on early childhood development has fueled an interest in interventions aimed at mitigating these harmful consequences. Psychosocial interventions aimed at alleviating the negative impacts of poverty on children are frequently shown to be of benefit, but ef...
journal_title:PLoS medicine
pub_type: 杂志文章,随机对照试验
doi:10.1371/journal.pmed.1002237
更新日期:2017-02-28 00:00:00
abstract::Hannah Leslie and co-authors discuss priorities in individual countries for health system reform. ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002946
更新日期:2019-10-03 00:00:00
abstract:BACKGROUND:Although gastric cancer has declined dramatically in the US, the disease remains the second leading cause of cancer mortality worldwide. A better understanding of reasons for the decline can provide important insights into effective preventive strategies. We sought to estimate the contribution of risk factor...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001451
更新日期:2013-01-01 00:00:00
abstract:BACKGROUND:Lifetime glycemic exposure and its relationship with age at diagnosis in type 2 diabetes (T2D) are unknown. Pharmacologic glycemic management strategies for young-onset T2D (age at diagnosis <40 years) are poorly defined. We studied how age at diagnosis affects glycemic exposure, glycemic deterioration, and ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003316
更新日期:2020-09-18 00:00:00
abstract:BACKGROUND:The SARS outbreak of 2002-2003 presented clinicians with a new, life-threatening disease for which they had no experience in treating and no research on the effectiveness of treatment options. The World Health Organization (WHO) expert panel on SARS treatment requested a systematic review and comprehensive s...
journal_title:PLoS medicine
pub_type: 杂志文章,评审
doi:10.1371/journal.pmed.0030343
更新日期:2006-09-01 00:00:00
abstract:BACKGROUND:The US Food and Drug Administration Amendments Act requires results from clinical trials of Food and Drug Administration-approved drugs to be posted at ClinicalTrials.gov within 1 y after trial completion. We compared the timing and completeness of results of drug trials posted at ClinicalTrials.gov and publ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001566
更新日期:2013-12-01 00:00:00
abstract:BACKGROUND:Previous estimates of mortality in Iraq attributable to the 2003 invasion have been heterogeneous and controversial, and none were produced after 2006. The purpose of this research was to estimate direct and indirect deaths attributable to the war in Iraq between 2003 and 2011. METHODS AND FINDINGS:We condu...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001533
更新日期:2013-10-01 00:00:00
abstract::Considerable progress has been made in reducing maternal, newborn, and child mortality worldwide, but many more deaths could be prevented if effective interventions were available to all who could benefit from them. Timely, high-quality measurements of intervention coverage--the proportion of a population in need of a...
journal_title:PLoS medicine
pub_type: 杂志文章,评审
doi:10.1371/journal.pmed.1001423
更新日期:2013-01-01 00:00:00
abstract:BACKGROUND:In June 2016, the first phase of the Chilean Food Labelling and Advertising Law that mandated front-of-package warning labels and marketing restrictions for unhealthy foods and beverages was implemented. We assess foods and beverages reformulation after this initial implementation. METHODS AND FINDINGS:A da...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003220
更新日期:2020-07-28 00:00:00
abstract::In an Editorial accompanying PLOS Medicine's Special Issue on Diabetes Prevention, Guest Editors Nicholas Wareham and William Herman discuss some of the challenges for researchers and policy makers in developing effective and equitable solutions to the worldwide problem of type 2 diabetes. ...
journal_title:PLoS medicine
pub_type: 社论
doi:10.1371/journal.pmed.1002097
更新日期:2016-07-26 00:00:00
abstract::Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order to achieve the levels of ...
journal_title:PLoS medicine
pub_type: 评论,杂志文章
doi:10.1371/journal.pmed.1001535
更新日期:2013-10-01 00:00:00
abstract:BACKGROUND:Average profiles of salivary progesterone in women vary significantly at the inter- and intrapopulation level as a function of age and acute energetic conditions related to energy intake, energy expenditure, or a combination of both. In addition to acute stressors, baseline progesterone levels differ among p...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0040167
更新日期:2007-05-01 00:00:00
abstract:BACKGROUND:The anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab improves outcomes in patients with node-positive HER2+ early breast cancer. Given trastuzumab's high cost, we aimed to estimate its cost-effectiveness by heterogeneity in age and estrogen receptor (ER) and progesterone r...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002067
更新日期:2016-08-09 00:00:00